Medical Director (Cardiology)
ICON plc
Summary
ICON is seeking a Medical Director specializing in Cardiology to join our Biotech Medical Affairs team. As a Medical Director at ICON, you will serve as a key medical and scientific partner to our biotech clients, providing therapeutic expertise throughout the lifecycle of clinical development programs.
Job description
What You Will Be Doing
- Provide medical and scientific leadership across clinical development programs within Cardiology.
- Serve as a trusted medical partner to biotech sponsors and ICON project teams throughout the study lifecycle.
- Provide medical monitoring and expert consultation on patient safety, eligibility, protocol-related questions, and other clinical issues arising during study conduct.
- Support the interpretation and application of study protocols from a medical and scientific perspective.
- Partner with Clinical Operations, Safety, Regulatory, and other cross-functional teams to identify and address medical risks that could impact study delivery.
- Provide therapeutic and scientific input into clinical development strategies and study planning.
- Participate in client meetings and provide medical expertise during proposal development, bid defenses, and other business development activities.
- Ensure medical and safety monitoring activities are conducted in accordance with applicable ethical, regulatory, and quality standards.
Your Profile
- Medical degree (MD or equivalent) required.
- US Board certification in Cardiology required.
- Clinical practice experience as a Cardiologist.
- Experience in clinical research, clinical trials, or drug development, ideally within a pharmaceutical, biotechnology, or CRO environment.
- Strong knowledge of cardiovascular medicine and the ability to apply clinical expertise within a clinical research setting.
- Understanding of GCP and the regulatory and ethical requirements associated with clinical trials.
- Strong communication skills with the ability to work effectively with biotech sponsors, investigators, and global cross-functional teams.
- Comfortable working in a client-facing environment where priorities may evolve as programs progress.
- Willingness to travel approximately 10–15%, as required.
Requirements
- Medical degree (MD or equivalent) required
- US Board certification in Cardiology required
- Clinical practice experience as a Cardiologist
- Experience in clinical research, clinical trials, or drug development
- Strong knowledge of cardiovascular medicine
- Understanding of GCP and regulatory and ethical requirements
- Strong communication skills
- Comfortable in client-facing environment
- Willingness to travel approximately 10–15%
Benefits
- Competitive base salary
- Performance related incentives
- Medical, Dental & Vision
- Retirement and pension plans
- Life assurance and disability coverage
- Employee assistance programmes
- Wellbeing resources
- Learning and development opportunities
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.